Photo of Hubert Vo
D Texas House · District 149

Rep. Hubert Vo

Compare
Total votes
7,829
all sessions
Attendance
88%
1,024 missed
Lower than 92% of chamber peers
With party
97%
of cast votes
Higher than 96% of chamber peers
Bipartisan score
2%
crosses aisle rarely
Lower than 98% of chamber peers
Sponsored
294
bills & resolutions
Lower than 98% of chamber peers
Committees
2
assignments
7,829 roll-call votes

Voting record

Yea
6,756
voted in favor
Nay
570
voted against
Absent
1,024
missed votes
Total cast
7,829
across all sessions
Crossed party
185
votes against own party
This page
7,829
matching current filters
Bill
Description
Vote
Result
Tally
Date
HB 3449
Relating to the reimbursement of expenses to certain counsel appointed to represent a defendant in a criminal proceeding.
Yea
Passed
135–1
May 13, 2025
HB 2464
Relating to the authority of a municipality to regulate a home-based business.
Yea
Passed
115–15
May 13, 2025
HB 3722
Relating to the height of a structure near certain airspace designated for use by Department of Defense contractors.
Nay
Passed
91–49
May 13, 2025
HB 2253
Relating to the authority to cancel certain elections on a measure to authorize the issuance of bonds.
Yea
Passed
98–38
May 13, 2025
HB 1533
Relating to the system for appraising property for ad valorem tax purposes.
Yea
Passed
137–0
May 13, 2025
HB 40
Relating to the business court.
Nay
Passed
99–40
May 13, 2025
HB 1052
Relating to health benefit plan coverage of telemedicine, teledentistry, and telehealth appointments with an originating site or distant site located outside this state.
Yea
Passed
114–26
May 13, 2025
HB 4580
Relating to the exemption from ad valorem taxation of property owned by certain nonprofit corporations and used to promote agriculture, support youth, and provide educational support in the community.
Yea
Passed
102–33
May 13, 2025
HB 4755
Relating to the authority of certain municipalities to use hotel occupancy tax revenue for certain venue projects.
Yea
Passed
96–27
May 13, 2025
SB 2308
Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.
Yea
Passed
138–1
May 13, 2025
Showing 1,541 to 1,550 of 7,829 votes